The 2 analysts offering 12-month price forecasts for Biora Therapeutics Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +400.95% increase from the last price of 1.00.
The current consensus among 2 polled investment analysts is to Buy stock in Biora Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.12
Reporting Date Aug 16
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.